← FDA DRUG APPROVALS

FDA ANDA · ANDA073340

PROMETA

Sponsor: MURO

APPLICATION
ANDA073340
TYPE
ANDA
ORIGINAL APPROVAL
1992-03-30
LATEST ACTION
1992-08-07
ROUTE
INHALATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

PROMETADiscontinued
METAPROTERENOL SULFATE 5% · SOLUTION · INHALATION

Approval history

1992-08-07Labeling · Supplement 1AP
1992-03-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →